Abstract
INTRODUCTION
Female-specific reproductive factors and exogeneous estrogen use are associated with cognition in later life. However, the underlying mechanisms are not understood. The present study aimed to investigate the effect of reproductive factors on neuroimaging biomarkers of Alzheimer’s disease (AD) and cerebrovascular pathologies.
METHODS
We evaluated 389 females (median age of 71.7 years) enrolled in the Mayo Clinic Study of Aging with reproductive history data and longitudinal magnetic resonance imaging (MRI) scans. We used linear mixed effect models to examine the associations between reproductive factors and changes in neuroimaging measures.
RESULTS
Ever hormonal contraception (HC) use was longitudinally associated with higher fractional anisotropy across the corpus callosum, lower white matter hyperintensity (WMH) volume, and greater cortical thickness in an AD meta-region of interest (ROI). The initiation of menopausal hormone therapy (MHT) > 5 years post menopause was associated with higher WMH volume.
DISCUSSION
HC use and initiation of MHT >5 years post menopause were generally associated with neuroimaging biomarkers of cerebrovascular pathologies.
Highlights
Hormonal contraception use was associated with better brain white matter (WM) integrity.
Initiation of menopausal hormone therapy >5 years post menopause was associated with worsening brain WM integrity.
Hormonal contraception use was associated with greater cortical thickness.
Ages at menarche and menopause and number of pregnancies were not associated with imaging measures.
There were few associations between reproductive factors or exogenous estrogens and amyloid or tau PET.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Jillian K. Lee,
Sheelakumari Raghavan,
Luke R. Christenson,
Ryan D. Frank,
Kejal Kantarci,
Walter A. Rocca,
Prashanthi Vemuri,
Michelle M. Mielke | June 11, 2024